Φορτώνει......
Evaluation of tafamidis as first-line therapeutic agent for transthyretin familial amyloidotic polyneuropathy
Almost 100 mutations in the human transthyretin (TTR) gene cause the autosomal dominant disorders of familial amyloidotic polyneuropathy (FAP) and familial amyloidotic cardiomyopathy. While these have been clinically classified as separate disorders, the peripheral and autonomic nervous systems and...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Degener Neurol Neuromuscul Dis |
|---|---|
| Κύριος συγγραφέας: | |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove Medical Press
2012
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6065585/ https://ncbi.nlm.nih.gov/pubmed/30890886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DNND.S24624 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|